Jewell Christopher M

CIK 00020002261 companyFREDERICK, MD

SEC Profile

Transactions

Companies

Filings

CIK

0002000226

Recent Transactions

20 trades

Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Stock Option (Right to Buy)
2025-01-10−9,000→ 67,432 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2025-01-10$3.23/sh+9,000→ 62,490 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2025-01-06$16.83/sh−1,286→ 53,490 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2025-01-03$16.72/sh−1,264→ 54,776 total
Award
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2025-01-02+16,100→ 56,040 total
Award
Cartesian Therapeutics, Inc.$RNAC
Employee Stock Option (right to buy)
2025-01-02+47,400→ 47,400 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2024-11-20$3.23/sh+14,000→ 39,940 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Stock Option (Right to Buy)
2024-11-20−14,000→ 76,432 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2024-11-15$3.23/sh+16,065→ 42,005 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2024-11-15$17.06/sh−16,065→ 25,940 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Stock Option (Right to Buy)
2024-11-15−16,065→ 90,432 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2024-11-14$16.34/sh−18,550→ 43,440 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2024-11-14$3.23/sh+36,050→ 61,990 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Stock Option (Right to Buy)
2024-11-14−36,050→ 106,497 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2024-11-14$17.02/sh−17,500→ 25,940 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Stock Option (Right to Buy)
2024-04-08−4,276.454→ 0 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Stock Option (Right to Buy)
2024-04-08+142,547→ 142,547 total
Award
Cartesian Therapeutics, Inc.$RNAC
Employee Stock Option (right to buy)
2024-01-02+998,000→ 998,000 total
Award
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2024-01-02+778,200→ 778,200 total
Award
Cartesian Therapeutics, Inc.$RNAC
Stock Option (Right to Buy)
2023-11-13+4,276.454→ 4,276.454 total

Companies

Cartesian Therapeutics, Inc.
Chief Scientific Officer
$RNAC

Recent Filings

Address

C/O CARTESIAN THERAPEUTICS, INC. 7495 NEW HORIZON WAY

FREDERICK, MD, 21703

View on SEC.gov